![1]() - News- Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit- May 18, 2021- The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close. 
![1]() - Opinion- Planning for SHM Converge 2022 now underway- May 17, 2021- SHM Converge 2022, scheduled for April 2002 in Nashville, will be the first in-person annual conference in three years. 
- News- Omics analysis links blood type to COVID-19- May 17, 2021- Within the ABO gene, the research also turned up evidence that blood type O may be protective against COVID-19. 
![1]() - News- PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI- May 15, 2021- When treating patients with no history of heart failure within days of an acute myocardial infarction, sacubitril/valsartan showed safety but no clear superiority to ramipril. 
![1]() - News- PHM groups issue Choosing Wisely® recommendations- May 14, 2021- The recommendations will allow pediatric hospitalists to lead change throughout their hospitals and health care systems. 
- News- Among asymptomatic, 2% may harbor 90% of community’s viral load: Study- May 14, 2021- “Walking around a college campus can be as dangerous as walking through a COVID ward in the hospital, in that you will experience these viral ‘supercarriers’ equally in both settings.” 
![1]() - News- Update in Hospital Medicine relays important findings- May 13, 2021- Two panelists highlighted the year of research in areas most relevant and important to hospital medicine. 
- News- CDC: Vaccinated? You don’t need a mask indoors- May 13, 2021- “Anyone who is fully vaccinated can participate in indoor and outdoor activities, large or small, without wearing a mask or physically distancing.” 
![1]() - News- Smart prescribing strategies improve antibiotic stewardship- May 13, 2021- Ruling out UTIs and limiting antibiotic duration in pneumonia patients can help reduce resistance and improve outcomes. 
- News- CDC recommends use of Pfizer’s COVID vaccine in 12- to 15-year-olds- May 13, 2021- ACIP voted 14-0 in favor of the safety and effectiveness of the vaccine in younger teens. 





